The emerging role of exosomes as novel therapeutics: Biology, technologies, clinical applications, and the next

Cited 41 time in webofscience Cited 24 time in scopus
  • Hit : 356
  • Download : 1441
DC FieldValueLanguage
dc.contributor.authorSong, Yongheeko
dc.contributor.authorKim, Youngeunko
dc.contributor.authorHa, Sunhyungko
dc.contributor.authorSheller-Miller, Samanthako
dc.contributor.authorYoo, Jaekwangko
dc.contributor.authorChoi, Chulheeko
dc.contributor.authorPark, Cheol Hyoungko
dc.date.accessioned2021-03-04T09:10:04Z-
dc.date.available2021-03-04T09:10:04Z-
dc.date.created2020-10-06-
dc.date.issued2021-02-
dc.identifier.citationAMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, v.85, no.2, pp.e13329-
dc.identifier.issn1046-7408-
dc.identifier.urihttp://hdl.handle.net/10203/281222-
dc.description.abstractThe extracellular vesicles (EVs) research area has grown rapidly because of their pivotal roles in intercellular communications and maintaining homeostasis of individual organism. As a subtype of EVs, exosomes are madeviaunique biogenesis pathway and exhibit disparate functional and phenotypic characteristics. Functionally, exosomes transfer biological messages from donor cell to recipient cell, which makes exosomes as a novel therapeutic platform delivering therapeutic materials to the target tissue/cell. Currently, both academia and industry try to develop exosome platform-based therapeutics for disease management, some of which are already in clinical trials. In this review, we will discuss focusing on therapeutic values of exosomes, recent advances in therapeutic exosome platform development, and late development of exosome therapeutics in diverse therapeutic areas.-
dc.languageEnglish-
dc.publisherWILEY-
dc.titleThe emerging role of exosomes as novel therapeutics: Biology, technologies, clinical applications, and the next-
dc.typeArticle-
dc.identifier.wosid000568336600001-
dc.identifier.scopusid2-s2.0-85090794388-
dc.type.rimsART-
dc.citation.volume85-
dc.citation.issue2-
dc.citation.beginningpagee13329-
dc.citation.publicationnameAMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY-
dc.identifier.doi10.1111/aji.13329-
dc.contributor.localauthorChoi, Chulhee-
dc.contributor.nonIdAuthorSong, Yonghee-
dc.contributor.nonIdAuthorKim, Youngeun-
dc.contributor.nonIdAuthorHa, Sunhyung-
dc.contributor.nonIdAuthorSheller-Miller, Samantha-
dc.contributor.nonIdAuthorYoo, Jaekwang-
dc.contributor.nonIdAuthorPark, Cheol Hyoung-
dc.description.isOpenAccessY-
dc.type.journalArticleArticle-
dc.subject.keywordAuthorclinical trial-
dc.subject.keywordAuthorexosomes-
dc.subject.keywordAuthorinflammatory diseases-
dc.subject.keywordAuthortherapeutic platform-
dc.subject.keywordPlusFACTOR-KAPPA-B-
dc.subject.keywordPlusEXTRACELLULAR VESICLES-
dc.subject.keywordPlusDELIVERY-
dc.subject.keywordPlusPROTEINS-
dc.subject.keywordPlusCELLS-
dc.subject.keywordPlusBIOGENESIS-
dc.subject.keywordPlusULTRACENTRIFUGATION-
dc.subject.keywordPlusCHARACTERIZE-
dc.subject.keywordPlusACTIVATION-
dc.subject.keywordPlusENRICHMENT-
This item is cited by other documents in WoS
⊙ Detail Information in WoSⓡ Click to see webofscience_button
⊙ Cited 41 items in WoS Click to see citing articles in records_button

qr_code

  • mendeley

    citeulike


rss_1.0 rss_2.0 atom_1.0